- Home
- CTM vs IKT Comparison
CTM vs IKT Comparison
Compare CTM & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTM
- IKT
- Stock Information
- Founded
- CTM 2019
- IKT 2008
- Country
- CTM United States
- IKT United States
- Employees
- CTM N/A
- IKT N/A
- Industry
- CTM EDP Services
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- CTM Technology
- IKT Health Care
- Exchange
- CTM Nasdaq
- IKT Nasdaq
- Market Cap
- CTM 119.9M
- IKT 140.5M
- IPO Year
- CTM N/A
- IKT 2020
- Fundamental
- Price
- CTM $1.01
- IKT $1.80
- Analyst Decision
- CTM Strong Buy
- IKT Buy
- Analyst Count
- CTM 1
- IKT 2
- Target Price
- CTM $3.00
- IKT $8.00
- AVG Volume (30 Days)
- CTM 2.4M
- IKT 98.2K
- Earning Date
- CTM 08-08-2025
- IKT 08-14-2025
- Dividend Yield
- CTM N/A
- IKT N/A
- EPS Growth
- CTM N/A
- IKT N/A
- EPS
- CTM N/A
- IKT N/A
- Revenue
- CTM $47,595,866.00
- IKT N/A
- Revenue This Year
- CTM $22.99
- IKT N/A
- Revenue Next Year
- CTM $3.68
- IKT N/A
- P/E Ratio
- CTM N/A
- IKT N/A
- Revenue Growth
- CTM 4.17
- IKT N/A
- 52 Week Low
- CTM $0.13
- IKT $1.12
- 52 Week High
- CTM $2.83
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- CTM 37.52
- IKT 52.36
- Support Level
- CTM $0.98
- IKT $1.77
- Resistance Level
- CTM $1.32
- IKT $1.87
- Average True Range (ATR)
- CTM 0.07
- IKT 0.15
- MACD
- CTM -0.01
- IKT 0.02
- Stochastic Oscillator
- CTM 18.33
- IKT 72.97
About CTM Castellum Inc.
Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.